Intensive BP Targets Cut Risk for Cardiac Conduction Disease
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
FRIDAY, May 5, 2023 -- Intensive blood pressure control is associated with a lower risk for left ventricular conduction disease, according to a study published online May 3 in JAMA Cardiology.
Emilie K. Frimodt-Møller, M.D., from the University of California in San Francisco, and colleagues examined the effectiveness of targeting intensive blood pressure control on the risk for developing left ventricular conduction disease. The analysis included 3,918 patients randomly assigned to standard treatment (<140 mm Hg systolic) and 3,956 to intensive treatment (<120 mm Hg systolic).
The researchers found that intensive treatment was associated with a lower risk for left ventricular conduction disease (hazard ratio, 0.74; 95 percent confidence interval, 0.56 to 0.98; P = 0.04). Results were similar when incident ventricular pacing was included in the outcome and when all-cause death was considered as a competing risk. There was no association observed between randomization assignment and the right bundle-branch block (hazard ratio, 0.95; 95 percent confidence interval, 0.71 to 1.27; P = 0.75).
"This analysis suggests that more aggressive blood pressure control might be a way to prevent this sort of common disease," a coauthor said in a statement. "More broadly, the use of randomized controlled trial data provides compelling evidence that this common disease is not an immutable fate, but that the risk can be modified."
One author disclosed financial ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2023
Read this next
Intensive HTN Treatment Cuts Early T2D Diagnosis-Linked CVD Event Risk
MONDAY, April 29, 2024 -- More intensive hypertensive therapy significantly reduces the excess risk for cardiovascular disease (CVD) events associated with earlier hypertension...
Antihypertensive Meds Initiation Linked to Fractures in Nursing Home Seniors
TUESDAY, April 23, 2024 -- For longer-term nursing home residents, initiation of antihypertensive medication is associated with an increased risk for fractures and falls...
Arrythmias Are a Significant Comorbidity in Adult Congenital Heart Disease
WEDNESDAY, April 17, 2024 -- For patients with adult congenital heart disease, arrythmias are a significant comorbidity and are associated with health care use and increased...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.